Stockscreener 앱 받기
6.48
6.75%
0.41
전일 마감가:
$6.07
열려 있는:
$6.46
하루 거래량:
78,958
Relative Volume:
3.09
시가총액:
$3.28M
수익:
-
순이익/손실:
$-17.06M
주가수익비율:
-0.0916
EPS:
-70.7173
순현금흐름:
$-14.18M
1주 성능:
+27.31%
1개월 성능:
-26.53%
6개월 성능:
-83.28%
1년 성능:
-93.76%
1일 변동 폭
$5.76
$6.65
1주일 범위
$5.1101
$7.32
52주 변동 폭
$4.93
$221.94
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
명칭
Cns Pharmaceuticals Inc
전화
1-800-946-9185
주소
2100 WEST LOOP SOUTH, HOUSTON
CNSP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
6.48 | 3.28M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-28 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | 개시 | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc 주식(CNSP)의 최신 뉴스
CNS Pharmaceuticals Surges 30% Intraday: What's Fueling This Biotech Breakout? - AInvest
Will CNS Pharmaceuticals Inc. Sustain Its Chart Breakout2025 Earnings Surprises & AI Powered Buy/Sell Recommendations - metal.it
Is it too late to sell CNS Pharmaceuticals Inc.July 2025 Levels & Precise Buy Zone Identification - Newser
What is the earnings history of CNS Pharmaceuticals Inc.Portfolio Gains Report & Safe Entry Point Identification - thegnnews.com
Predicting CNS Pharmaceuticals Inc. trend using moving averagesWeekly Gains Report & Stepwise Entry/Exit Trade Alerts - Newser
Heatmap analysis for CNS Pharmaceuticals Inc. and competitorsJuly 2025 Short Interest & AI Powered Market Entry Strategies - Newser
Detecting price anomalies in CNS Pharmaceuticals Inc. with AI2025 Investor Takeaways & Long-Term Safe Investment Plans - Newser
CNS Pharmaceuticals Inc. stock prediction for this weekWeekly Investment Report & Fast Entry Momentum Alerts - Newser
Will CNS Pharmaceuticals Inc. outperform the marketJuly 2025 Macro Moves & Low Risk Entry Point Guides - Newser
CNS Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Earnings & Weekly Chart Analysis and Guides - Newser
What’s the recovery path for long term holders of CNS Pharmaceuticals Inc.2025 Major Catalysts & Breakout Confirmation Trade Signals - Newser
Market reaction to CNS Pharmaceuticals Inc.’s recent newsRisk Management & Fast Moving Market Watchlists - Newser
Why CNS Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Stock Summary & Verified Entry Point Signals - Newser
Using data tools to time your CNS Pharmaceuticals Inc. exitMarket Weekly Review & Fast Entry High Yield Stock Tips - Newser
What recovery options are there for CNS Pharmaceuticals Inc.2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
CNS Pharmaceuticals reports Q2 EPS ($6.42) vs. ($4,049.20) last year - TipRanks
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series, Biotech, MedTech - MarketScreener
Brain Cancer Breakthrough: CNS Pharma's TPI 287 Shows 52% Response Rate in Phase 1 GBM Trial - Stock Titan
CNS Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks
Brain Cancer Treatment Developer CNS Pharmaceuticals Joins Webull's Virtual Biotech Conference - Stock Titan
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - FinancialContent
Earnings visualization tools for CNS Pharmaceuticals Inc.AI Generated Momentum Stock Forecast Guide - Newser
CNS Pharmaceuticals CNSP 2025Q2 Earnings Preview Downside Risk Amid Market Uncertainties - AInvest
What makes CNS Pharmaceuticals Inc. stock price move sharplyTechnical Entry Plan with Risk Minimization - Newser
Can machine learning forecast CNS Pharmaceuticals Inc. recoveryMarket Stability and Long-Term Growth Outlook - Newser
Central Nervous System (CNS) Therapeutics Market Forecast - openPR.com
What analysts say about CNS Pharmaceuticals Inc. stockGet alerts on high-potential market moves - Jammu Links News
Is CNS Pharmaceuticals Inc. stock overvalued or undervaluedRapid growth trajectories - Jammu Links News
Should I hold or sell CNS Pharmaceuticals Inc. stock in 2025Free Trend-Following Techniques - Jammu Links News
When is CNS Pharmaceuticals Inc. stock expected to show significant growthRapid-fire capital growth - Jammu Links News
CNS Pharmaceuticals Inc. Stock Analysis and ForecastPhenomenal capital gains - Jammu Links News
What catalysts could drive CNS Pharmaceuticals Inc. stock higher in 2025Maximize returns with strategic portfolio planning - Jammu Links News
Why is CNS Pharmaceuticals Inc. stock attracting strong analyst attentionDynamic profit expansion - Jammu Links News
What are analysts’ price targets for CNS Pharmaceuticals Inc. in the next 12 monthsAmplify your gains with low-risk picks - Jammu Links News
What is the risk reward ratio of investing in CNS Pharmaceuticals Inc. stockHigh-performance stocks for savvy investors - Jammu Links News
How volatile is CNS Pharmaceuticals Inc. stock compared to the marketBuild a portfolio that outperforms consistently - Jammu Links News
What is the dividend policy of CNS Pharmaceuticals Inc. stockFinancial News Outlook For 2025 - Jammu Links News
Ranking CNS Pharmaceuticals Inc. among high performing stocks via toolsHigh Probability Trade Plan with Indicators - Newser
CNS Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySwing Setup With Technical Confirmation Explained - metal.it
How does CNS Pharmaceuticals Inc. compare to its industry peersBeginner Investor Watchlist For 2025 - Jammu Links News
Published on: 2025-07-28 14:09:47 - metal.it
Will CNS Pharmaceuticals Inc. outperform the market Free Buy Low Sell High Stock Watch - Newser
Is it the right time to buy CNS Pharmaceuticals Inc. stockHigh-yield investments - Jammu Links News
What makes CNS Pharmaceuticals Inc. stock price move sharply 2-Day Signal Watch with Forecast Outcome - metal.it
How strong is CNS Pharmaceuticals Inc. company’s balance sheetExplosive earnings growth - Jammu Links News
Does CNS Pharmaceuticals Inc. stock perform well during market downturnsUnprecedented market success - Jammu Links News
Published on: 2025-07-27 20:34:14 - Jammu Links News
What drives CNS Pharmaceuticals Inc. stock priceFree Stock Movement Tracking - Autocar Professional
Cns Pharmaceuticals Inc (CNSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
1.72%
자본화:
|
볼륨(24시간):